V | C | S | E | δPv | δPu | δS | δE |
---|
90% | 90% | 90% | 90% | −0.6 | −0.6 | −0.6 | −0.6 |
80% | 80% | 80% | 80% | −0.4 | −0.4 | −0.4 | −0.4 |
70% | 70% | 70% | 70% | −0.2 | −0.2 | −0.2 | −0.2 |
60% | 60% | 60% | 60% | 0 | 0 | 0 | 0 |
50% | 50% | 50% | 50% | 0.2 | 0.2 | 0.2 | 0.2 |
 | 40% | 40% |  | 0.4 | 0.4 | 0.4 | 0.4 |
 | 30% | 30% |  | 0.6 | 0.6 | 0.6 | 0.6 |
 | 20% | 20% |  |  |  |  |  |
 |  | 10% |  |  |  |  |  |
- V =Vaccine effectiveness.
- C = Vaccination coverage.
- S = Screening uptake.
- E = Baseline lifetime screening sensitivity (the sensitivity of the screening program).
- δPv = Proportional change in the risk of infections caused by vaccine strains which would cause cervical cancer if nether prevented nor detected.
- δPu = Proportional change in the risk of infections caused by non-vaccine strains which would cause cervical cancer if nether prevented nor detected.
- δS =Proportional change in screening uptake.
- δE = Proportional change in lifetime screening sensitivity.